Ajax-Loading

AstraZeneca PLC - Accounts Payable

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Accounts-Payable" stands at 23.01 Billion United States Dollars as of 06/30/2026.

As of the end of AstraZeneca PLC's second quarter, the item "Accounts Payable" stands at 23.01 Billion USD. This represents an increase of 2.25 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.06 percent compared to the value the year prior.
The 1 year change in percent is -4.06.
The 3 year change in percent is 16.59.
The 5 year change in percent is 29.80.
The 10 year change in percent is 124.31.

The Serie's long term average value is 12.17 Billion United States Dollars. It's latest available value, on 06/30/2026, is 89.06 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2026, is +1,269.75%.
The Serie's change in percent from it's maximum value, on 12/31/2025, to it's latest available value, on 06/30/2026, is -8.97%.

Accounts Payable for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Accounts Payable905,699,262,464.00
LogoJohnson & Johnson - Accounts Payable486,508,953,600.00
LogoAbbVie Inc - Accounts Payable399,570,305,024.00
LogoRoche Holding AG - Accounts Payable317,433,206,677.55
LogoNovartis AG - Accounts Payable255,096,620,580.91